Accessibility Menu
Ayala Pharmaceuticals Stock Quote

Ayala Pharmaceuticals (OTC: ADXS)

$0.03
(0.0%)
+0.00
Price as of October 17, 2025, 10:38 a.m. ET

KEY DATA POINTS

Current Price
$0.03
Daily Change
(0.0%) +$0.00
Day's Range
$0.03 - $0.03
Previous Close
$0.03
Open
$0.03
Beta
-8.30
Volume
102
Average Volume
787
Market Cap
1.4M
Market Cap / Employee
$0.03M
52wk Range
$0.03 - $0.8
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
$0
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Ayala Pharmaceuticals Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ADXS+23.33%-99.92%-75.7%-96%
S&P+15.06%+95.03%+14.29%+57%

Ayala Pharmaceuticals Company Info

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded in November 2017 and is headquartered in Monmouth Junction, NJ.

Financial Health

General

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available for this period.

Liabilities

No data available for this period.

Ratios

No data available for this period.

Cash Flow

No data available for this period.

Valuation

MetricYoY Change

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.